Cangrelor Use Patterns and Transition to Oral P2Y₁₂ Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry.

ABSTRACT: Background In clinical trials, cangrelor has been shown to reduce percutaneous coronary intervention-related ischemic complications without increasing major bleeding. This study was performed to examine cangrelor use and transition to oral P2Y₁₂ inhibitors in routine clinical practice. Methods and Results The CAMEO (Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes) registry is a multicenter, retrospective observational study of platelet inhibition strategies for patients with myocardial infarction undergoing percutaneous coronary intervention. In phase 1, data were collected on consecutive patients with myocardial infarction (n=482) treated with any P2Y₁₂ inhibitor to understand cangrelor use by hospital. In phase 2, data were collected in a 2:1 (c

SUBMITTER: Rymer JA 

PROVIDER: S-EPMC9238709 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature